211915-06-9: Dabigatran Etexilate

Dabigatran Etexilate(CAS No: 211915-06-9) or :3-{[(2-{[(4-{N’-hexyloxycarbonyl carbamimidoyl}phenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-pyridin-2-yl-amino)propanoic acid ethyl ester, is a potent, concentration-dependent inhibitor of thrombus formation and prevention of venous thromboembolism

Additional information on CAS 211915-06-9

Catalogue No.

VE008337

CAS No.

211915-06-9

Molecular Formula

C34H41N7O5

Molecular Weight

627.73 g/mol

Parent drug

Dabigatran

IUPAC Name

3-{[(2-{[(4-{N'-hexyloxycarbonyl carbamimidoyl}phenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-pyridin-2-yl-amino)propanoic acid ethyl ester

Synonyms

N/A

References

Dabigatran Etexilate By Mark Sanford, Greg L Plosker Container: Drugs Year: 2008 Volume: 68 Issue: 12 DOI: 10.2165/00003495-200868120-00007 URL: https://link.springer.com/article/10.2165/00003495-200868120-00007

Status

In-stock

[rfq_list]

Login first to add product to RFQ List

Request a quote

211915-06-9: Dabigatran Etexilate

211915-06-9: Dabigatran Etexilate
Catalogue No.

VE008337

CAS No.

211915-06-9

Molecular Formula

C34H41N7O5

Molecular Weight

627.73 g/mol

Parent drug

Dabigatran

IUPAC Name

3-{[(2-{[(4-{N'-hexyloxycarbonyl carbamimidoyl}phenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-pyridin-2-yl-amino)propanoic acid ethyl ester

Synonyms

N/A

References

Dabigatran Etexilate By Mark Sanford, Greg L Plosker Container: Drugs Year: 2008 Volume: 68 Issue: 12 DOI: 10.2165/00003495-200868120-00007 URL: https://link.springer.com/article/10.2165/00003495-200868120-00007

Status

In-stock

ListName

Dabigatran Etexilate

Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden